Format

Send to

Choose Destination
Mech Ageing Dev. 2010 Jul-Aug;131(7-8):527-35. doi: 10.1016/j.mad.2010.06.002. Epub 2010 Jun 8.

Mitochondrial oxidative stress and mammalian healthspan.

Author information

1
Department of Medicine, Division of Geriatrics, UCLA, Los Angeles, CA 90095, USA.

Abstract

Aging of the American society is leading to a growing need for disease-modifying interventions to treat age-related diseases and enhance healthspan. Mitochondria and mitochondrially generated reactive oxygen species appear to play a central role in these processes and are a likely target for interventions. Conventional, untargeted antioxidants have not demonstrated a clear benefit in human studies. As a result, approaches have been developed to target antioxidants specifically to mitochondria. Studies have employed a wide array of targeted molecules including antioxidant enzymes such as catalase, peroxiredoxin, superoxide dismutases and small molecular compounds which recapitulate the antioxidant activities of these enzymes. Lifespan and healthspan effects differ between interventions suggesting varied roles for specific mitochondrial reactive oxygen species and their impact on usual aging. Consistent findings in myocardial protection across various interventions support a focus on the impact of cardiac aging on healthspan. The advancement of mitochondrially targeted small-molecule antioxidants suggests the prospect of swift translation to human use.

PMID:
20566356
PMCID:
PMC2933331
DOI:
10.1016/j.mad.2010.06.002
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center